Binding of Ulex europaeus lectin to microvessels was used to isolate endothelial cells from cycling human endometrium. Cultured human endometrial endothelial cells (HEECs) exhibited endothelial cell-specific characteristics such as tube formation on a basement membrane matrix and sequestration of acetylated low-density lipoprotein. Markers for potentially contaminating epithelial, stromal, smooth muscle, and bone marrow-derived cells were not detected in the HEEC cultures. Basal and proinflammatory-stimulated immunostaining profiles for endothelial cell-specific adhesion markers, as exemplified by Von Willebrand's factor and E-selectin, were similar for cultured HEECs and human umbilical venous cord endothelial cells (HUVECs). However, HUVECs expressed several extracellular matrix proteins that were absent from cultured HEECs. In the latter, the protein kinase C agonist phorbol myristate acetate transiently enhanced tissue factor (TF) mRNA levels and elicited a more prolonged elevation in TF protein levels, but did not affect plasminogen activator inhibitor-1 (PAI-1) mRNA and protein levels. Inappropriate expression of TF, which initiates hemostasis by generating thrombin, and of PAI-1, which regulates hemostasis by acting as the primary inhibitor of fibrinolysis, can each lead to thrombosis. The differential regulation of TF and PAI-1 expression revealed in the current study emphasizes the importance of using HEECs to evaluate mechanisms regulating the hemostatic/thrombotic balance in human endometrium.
INTRODUCTION
During human implantation, blastocyst-derived trophoblasts breach endometrial blood vessels and establish the primordial uteroplacental circulation. Concomitantly, endovascular trophoblasts begin to replace the spiral arterial endothelial lining and remodel the intima and media of these vessels [1] . These processes provide the developing embryo with a requisite source of oxygen and nutrients, and are therefore key to reproductive success. However, they present contradictory hemostatic challenges. Thus, decidual hemorrhage can stem from inadequate hemostasis in these remodeled vessels. Alternatively, continued embryo survival requires maintenance of blood fluidity, thereby 1 This work was supported in part by a grant from the National Institutes of Health RO1 HD33937-05 (C.J.L.) and M01 RR 00096 (GCRC). The current study sought to isolate HEECs from specimens of cycling tissue, with the goal of developing a relevant in vitro model for evaluating HEEC physiology and pathology. By examining morphological characteristics and antigen expression, it aimed to validate the endothelial nature of the cultured HEECs and to establish their homogeneity by ruling out the presence of extraneous cell types. An extensive number of concepts in vascular biology have relied on the in vitro behavior of human umbilical venous cord endothelial cells (HUVECs). However, HUVECs are derived from a type of vessel that is not affected by atherosclerosis, the most common of human vascular disorders [2] . The protein kinase C agonist phorbol myristate acetate (PMA) induces the expression of tissue factor (TF) and plasminogen activator (PA) inhibitor 1 (PAI-1) in cultured HUVECs and in endothelial cells derived from other large vessels such as saphenous veins and bovine aortas [3] [4] [5] [6] [7] .
Since TF is the primary mediator of hemostasis [8] and PAI-1 affects hemostasis by acting as the fast inactivator of fibrinolysis [9] , we examined PMA effects on TF and PAI-1 expression in cultured HEECs in order to initiate direct studies of the hemostatic-thrombotic balance in human endometrium.
MATERIALS AND METHODS

Tissues
Specimens of cycling endometrium were obtained from consenting patients undergoing hysterectomy for myomas and were transported to a sterile laminar flow hood. A small portion of each specimen was formalin-fixed and histologically dated by the criteria of Noyes et al. [10] , and endothelial cells were isolated from the remainder. A portion of some specimens were frozen in OCT (Miles Inc., Elkhart, IN) in cold 2-methyl butane and were sectioned for fluorescent lectin staining.
Lectin Staining of Endometrium
Frozen sections of human endometrium were incubated for 30 min at 4ЊC with fluorescein-labeled lectins (Sigma, St. Louis, MO) diluted 1:50 in PBS and then washed with buffer (2 mM Tris-HEPES, 140 mM NaCl at pH 7.4) to remove free lectin. The slides were fixed in absolute ethanol for 40 min, air-dried, examined by fluorescence microscopy, and photographed. HEECs. Endometrial specimens were dissected free of visible vascular tissue, minced in Ca 2ϩ /Mg 2ϩ -free PBS (Cell Systems Corp., Kirkland, WA) ϩ 1% dialyzed fetal bovine serum (FBS) (HyClone, Logan, UT), and digested with type VII high-purity collagenase (Sigma) and dispase (Boehringer Mannheim, Indianapolis, IN) in the presence of deoxyribonuclease (DNase) I (Sigma) and 1% dialyzed fetal bovine serum (FBS). The digest was filtered through a 70-m cell strainer (Falcon; Becton-Dickinson, Franklin Lakes, NJ) to remove undigested tissue fragments. The filtrate was treated with 1 mg/ml of biotinylated UEA-1 (Ulex europaeus) lectin (Sigma), which binds selectively to microvascular endothelial cells in human endometrial sections (see Fig. 1 ). Biotinylated UEA-1 labeled cells were separated from nonlabeled cells by panning on activated surface/AIS MicroCELLector flasks (Applied Immune Sciences, Menlo Park, CA) coated with streptavidin (Sigma). The reaction mixture contained 10 7 cells incubated at 4ЊC with 0.1 ml UEA-1.
Cells retained on the MicroCELLector flasks were released and cultured in CS-C Complete Medium (phenol red-free DMEM:Ham's F-12 [1:1] with 15 mM HEPES, containing endothelial cell growth factor) supplemented with 15% stripped fetal calf serum in flasks coated with attachment factor (Cell Systems). A typical yield from 1.5 g of tissue exceeded 5 ϫ 10 5 UEA-1-positive cells in a primary culture. The HEECs were grown to confluence in a 37ЊC, 95% air:5% CO 2 incubator, with the medium changed every two days, and they were harvested with the CS-C Passage Reagent Group, which involves the sequential use of EDTA, trypsin-EDTA, and trypsin inhibitor solutions (Cell Systems). Cells were split 1: 6 for passaging.
Human endometrial stromal cells. Endometrial stromal cells were isolated to homogeneity from fragments of cycling endometrium and cultured as previously described [11, 12] . Briefly, the fragments were digested with type 1 collagenase (Worthington Biochemical Corp., Freehold, NJ); then the digestate was filtered through a 38-m stainless steel sieve to remove the glands. The filtrate was centrifuged on a 30-60% Percoll gradient to produce a stromal cell-enriched layer at the interface. The stromal cells were purified to virtual homogeneity by exploiting their more rapid adherence to the surface of polystyrene tissue culture dishes (30 min in a 37ЊC, 95% air:5% CO 2 incubator) than that of contaminating cell types.
HUVECs and human vascular smooth muscle cells. HUVECs and vascular smooth muscle cells, which were derived from umbilical arteries, were obtained from Cell Systems and cultured as described for HEECs.
Characterization of Cultured Cells
Morphology. Second-passage HEECs were suspended in CS-C Complete Medium and seeded (3000 cells/mm 2 ) on either 25-mm cell culture inserts coated with Matrigel (Collaborative Biomedical Products Inc., New Bedford, MA), or on attachment factor-coated plastic (Cell Systems), and allowed to grow to confluence. Scanning electron microscopy (SEM) was carried out with a Hitachi (Tokyo, Japan) S530 Scanning Electron Microscope, after the cultures were postfixed in 3% gluteraldehyde:1% OsO 4 .
Antigen expression. Cultured HEECs, HUVECs, human vascular smooth muscle cells, and human endometrial stromal cells were each fixed for 5 min in ice-cold absolute methanol and then incubated with primary monoclonal antibodies that were obtained from either Becton-Dickinson or Sigma, and used at a dilution of 1:250 in PBS. Indirect fluorescence was carried out after incubation with fluorescein-conjugated second antibody (Dako, Copenhagen, DK) used at a dilution of 1:50. A semiquantitative scoring system with a range of staining intensity-none (Ϫ), weak (ϩ), moderate (ϩϩ), strong (ϩϩϩ), and intense (ϩϩϩϩ)-was used to assess relative immunofluorescence.
Regulation of TF and PAI-1 expression. Confluent HEECs were starved for 3 h in M 199 (Gibco, Grand Island, NY) in a 37ЊC, 95% air:5% CO 2 incubator. The medium was exchanged for a serum-free defined medium lacking growth factor (SF-4Z0-500-S; Cell Systems) containing PMA (Sigma) or 0.1% ethanol, the vehicle used to dissolve PMA. When the incubations were terminated, the collected media were centrifuged, and the supernatants and harvested cell pellets were stored at Ϫ70ЊC. Parallel cultures were frozen on dry ice and stored at Ϫ70ЊC for RNA extraction.
Northern blot analysis. Total RNA was extracted from cultured HEECs by guanidinium thiocyanate-chloroform. Approximately 15 g total RNA from each of the experimental cultures, and molecular weight RNA standards (Boehringer-Mannheim) were separated on a 1% agarose gel containing 2.2 M formaldehyde, then transferred to a Zeta-Probe nylon membrane (Bio-Rad Labs., Hercules, CA). Levels of TF and PAI-1 mRNA were detected using previously described probes [11, 13] , which were labeled with [ 32 P]deoxy-CTP to high specific activity by random priming with a Boehringer-Mannheim kit. Hybridization was performed by standard methods, and the washed filters were exposed to Kodak XAR film (Eastman Kodak, Rochester, NY). Total RNA loads were standardized by reprobing the stripped membranes with a 32 P-labeled probe for actin.
Biochemical assays. Sensitive ELISAs (American Diagnostica, Greenwich, CT) were used to measure immunoreactive TF levels in the cell pellets and PAI-1 levels in the cell-conditioned medium as described [11, 13] . Protein and DNA content were measured in aliquots of the cell pellets by the Bio-Rad assay (Bio-Rad Labs.) and the method of Hinegardner [14] , respectively.
RESULTS
UEA-1 Expression in Human Endometrial Vessels and in Cultured HEECs
Lectin binding to specific surface determinants has proven useful in cell isolation. Figure 1A indicates that Dolichos biflorus agglutinin, which binds to endothelial cells of developing brain vasculature [15] , stained the apical surface of human endometrial glands but did not significantly stain either the stromal cells or vessels. By contrast, Figure 1B reveals that the vasculature displayed prominent staining for UEA-1, which binds to blood vessels in bone marrow [16] . Only minimal UEA-1 staining was evident in either glands or stroma.
As described in Materials and Methods, binding of UEA-1 to endometrial microvasculature was used to isolate HEECs. Figure 2A indicates that fluorescein-conjugated UEA-1 decorated the surface of endothelial cell-enriched endometrial fragments obtained after panning. Moreover, the uniform fluorescence shown in Figure 2B indicates that recognition of UEA-1 was preserved in second-passage HEECs grown on attachment factor-coated tissue culture plastic.
Characterization of Cultured HEECs
Phase-contrast microscopy ( Fig. 3A) and SEM (Fig. 3C) indicated that the HEECs formed flattened monolayers on attachment factor-coated tissue culture plastic. By contrast, parallel cultures grown on Matrigel, a basement membrane extract, organized into networks of tube-like structures as evidenced by both phase-contrast microscopy ( Fig. 3B) and SEM (Fig. 3D) . Figure 4 reveals intense localization of the endothelial cell-specific marker, Di-I-Ac-LDL in both the monolayers (Fig. 4A ) and the capillary-like tubes (Fig. 4B) . Table 1 shows the results of subjecting monolayer cultures of HEECs, HUVECs, human endometrial stromal cells, and vascular smooth muscle cells to immunostaining with panels of fluorescein-labeled monoclonal antibodies. Both HEECs and HUVECs displayed similar staining patterns for an array of endothelial cell specific surface markers. These included Von Willebrand's factor (VWF), as well as adhesion molecules involved in leukocyte trafficking. Of the latter group, the expression of E-selectin, intercellular adhesion molecule 1 (ICAM-1), very late activation antigen 4 (VLA-4), lymphocyte function-associated antigen 1␤ (LFA-1␤), and vascular cell adhesion molecule 1 (VCAM-1) was either enhanced or induced by a pro-inflammatory cytokine in both HEECs and HUVECs. By contrast, HUVECs strongly expressed several extracellular matrix (ECM) proteins (i.e, collagen IV, chondroitin sulfate, heparan sulfate, and fibronectin) that were absent from, or barely detected in, the cultured HEECs. Table 1 also indicates that human endometrial stromal cells stained for fibronectin, and vascular smooth muscle cells stained for vinculin and fibronectin, whereas the HEECs failed to immunostain for either marker. Moreover, neither the epithelial cell marker cytokeratin nor markers of bone marrow-derived cells were detected in the cultured HEECs. Figure 5A indicates that after a 2-h incubation with 25 ng/ml PMA, levels of immunoreactive (ir) TF were elevated in the HEEC cultures by 15-fold. After 19 h, basal TF levels were essentially unchanged, whereas PMA-enhanced levels of ir TF had decreased to about 40% of the levels attained at 2 h. By contrast, Figure 5B shows that HEECsecreted levels of ir PAI-1 were unaffected by PMA at both time points. However, basal levels of PAI-1 had increased by 20-fold at 19 h compared with 2 h, thereby attesting to the viability of the HEECs during incubation in the serum- 
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a Primary antibodies used to detect adhesion molecules were from Becton-Dickinson; the other primary antibodies were from Sigma; scoring intensity was carried out as described in Materials and Methods. free defined medium. While the effects of PMA shown in Figure 5 were obtained with fifth-passage HEECs, enhanced TF levels and unaltered PAI-1 levels were also seen in confluent third-and sixth-passage HEECs. These results suggest that the HEEC phenotype is stable in vitro. Figure  6 indicates that PMA elicited a dose-dependent increase in TF levels in the HEEC monolayers and confirms that PMA did not alter levels of immunoreactive PAI-1. Western blotting of cell extracts and conditioned medium, respectively, confirmed the ELISA results for TF and PAI-1 (data not shown). Consistent with the PMA enhancement of TF protein expression, the Northern blot shown in Figure 7 indicates that PMA elicited a transient time-dependent elevation in steady-state levels of TF mRNA. A several-fold increase in TF mRNA levels was evident at 2 h of incubation. As expected, PMA did not affect levels of either the 2.2-or 3.2-kilobase species of PAI-1 mRNA.
DISCUSSION
This study sought to characterize and culture endothelial cells isolated by binding of UEA-1 lectin to vessels in the endometrial layer with the goal of developing an in vitro model for evaluating the regulation of human endometrial hemostasis. Several criteria validated the endothelial nature of the HEECs. Unlike the flattened monolayers that formed on attachment factor-coated tissue culture plastic, HEECs organized into networks of tube-like structures on the base-
Effects of PMA on TF and PAI-1 mRNA expression in cultured HEECs. Confluent fifth-passage HEECs were starved for 3 h, then incubated in parallel in a defined medium containing 0.1% ethanol (vehicle control) or 25 ng/ml PMA for up to 6 h. At each time point, total cell RNA was extracted and subjected to Northern blot analysis. Steady-state levels of actin mRNA were used to normalize differences in RNA loading. ment membrane component substrate Matrigel. Tube formation by endothelial cells grown in contact with ECM components is thought to reflect angiogenesis [17] [18] [19] . By contrast, our previous studies showed that when grown in contact with Matrigel and/or collagen I gels, human endometrial glandular epithelial cells form polarized monolayers on the gel surface [20] , whereas human endometrial stromal cells and decidualized stromal cells penetrated and formed clusters within the gel [21, 22] . Consistent with uptake and sequestration of acetylated low-density lipoprotein (LDL) by a well-described endothelial cell/megakaryocyte-specific mechanism [23] , cultured HEECs stained intensely for the presence of the fluorescent adduct Di-I-Ac-LDL. Fluorescent microscopy of cultured HEECs performed after incubation with panels of monoclonal antibodies rigorously established the homogeneity of the cultured HEECs. Thus, prominent immunostaining was seen for such endothelial cell-specific surface markers as VWF, which regulates hemostasis by binding to platelet receptors [24] , and mediators of leukocyte trafficking, such as E-selectin, ICAM-1, VLA-4, LFA-1␤, and VCAM-1 [25] . In contrast, cultured HEECs did not display markers of likely epithelial, stromal, smooth muscle, and bone marrow-derived cell contaminants. Moreover, consistent with their microvascular origin, HEECs did not express several ECM proteins that were readily detected in cultures of the large vessel-derived HUVECs. These observations underscore the importance of employing HEECs for studies of HEEC biology.
Induction of TF expression transforms the endothelial cell membrane from an anticoagulant to a pro-coagulant surface. TF is a glycoprotein comprising a hydrophilic extracellular domain, a membrane-spanning hydrophobic domain, and a cytoplasmic tail [8, 26] . It serves as the transmembrane cell receptor for factor VII and its activated form (VIIa). Binding to TF markedly accelerates factor VIIa-dependent activation of factors X and IX, which promotes conversion of prothrombin to thrombin [27] . TF is localized below, between, and on the surface [28, 29] of cultured endothelial cells. Upon exposure to plasma, endothelial cell-expressed TF generates thrombin, which forms fibrin on the endothelial cell surface [30] . The in vitro expression of TF in endothelial cells such as HUVECs is enhanced by diverse stimuli. Continuous exposure to various agonists initially results in up-regulation of TF mRNA and protein levels, followed by a decline in TF expression. This characteristic biphasic response is thought to constitute a mechanism that limits fibrin formation on the endothelial cell surface [2] . Thus, the observations in the current study that TF mRNA and protein levels were up-regulated in cultured HEECs after exposure to PMA, and that this up-regulation was followed by a rapid decline in TF mRNA levels and a slower decline in TF protein levels, provide an expected and important measure of endothelial cell function.
In several endothelial cell types, the expression of PAI-1, a member of the SERPIN family of antiproteases, is enhanced by growth factors and cytokines (reviewed in [2] ). Endothelial cell-derived PAI-1 is deposited in the underlying ECM, where it is bound to plasma-derived vitronectin [31] , which stabilizes the biological activity of PAI-1. Active PAI-1 promotes hemostasis by serving as the ''fast inhibitor'' of tissue-type PA, the primary fibrinolytic agent [9] . However, over-expression of PAI-1, especially in conjunction with over-expressed TF, is associated with thrombosis [32] .
The current study indicates that PMA-enhanced TF expression in cultured HEECs was not accompanied by alterations in PAI-1 mRNA or protein expression. Thus, unlike TF, PAI-1 synthesis may not be mediated by protein kinase C in HEECs. As TF and PAI-1 affect the hemostatic/thrombotic balance by different mechanisms, the differential regulation of TF and PAI-1 in cultured HEECs emphasizes the relevance of these cells as a model with which to investigate the physiological regulation of, and pathological changes in, endometrial hemostasis. The latter includes nonpregnant conditions such as abnormal uterine bleeding due to fibroids, as well as uterine bleeding secondary to contraception or hormone replacement therapy. Moreover, abnormal hemostasis in HEECs is probably involved in perinatal and maternal morbidity and mortality associated with decidual hemorrhage as occurs in abruptions, and with various uteroplacental thrombotic conditions such as intrauterine fetal growth retardation, preeclampsia, and stillbirth.
This initial study stressed the use of cultured HEECs to investigate the regulation of hemostasis/thrombosis in human endometrium. However, the microvasculature is clearly involved in virtually every aspect of endometrial biology, with corresponding reproductive implications. Thus, by regulating uptake of oxygen, nutrients, and ovarian steroids, these vessels perforce control growth and differentiation of the functional endometrial layer. Moreover, elaboration of adhesion molecules on the endothelial cell surface is expected to control leukocyte trafficking into the endometrium [33] . Predictably, the resident endometrial leukocyte population will determine the composition of the cytokine milieu and thus affect such widespread processes as endovascular trophoblast invasion as well as the expression of proteases involved in degradation of the endometrial ECM leading to menstruation. The novel in vitro model described in the current study should permit direct investigations of these phenomena.
